Published: 2024-10-28
Emil Billbäck, CEO, has sold 172,600 shares for personal financial reasons. After the transaction, he owns 363,571 shares.
Dr. Michael Diefenbeck, Chief Medical Officer and EVP Clinical Affairs, has sold 18,000 shares to cover tax effects and pay the exercise price for the employee 2016 stock options program. After the transaction, he owns 84,160 shares.